1. Hong Kong Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
SSY Group Limited

SSY Group Limited

HHKEX:2005
2.58
HKD
-0.07
(-2.64%)
8.22BMarket Cap
Mar 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.59
0.71
0.76
0.83
1.08
1.4
1.53
1.41
1.77
2.16
2.18
1.95
1.42
- -
Basic EPS, GAAP
0.14
0.2
0.14
0.17
0.23
0.3
0.38
0.2
0.26
0.38
0.44
0.36
0.16
- -
Free Cash Flow per Basic Share
-0.11
-0.19
0.05
0.13
0.06
0.13
-0.06
0.06
0.1
0.11
0.07
-0.02
0.1
- -
Dividend per Share
0.04
0.08
0.2
0.03
0.06
0.08
0.1
0.11
0.1
0.13
0.15
0.18
0.15
- -
Book Value per Share
0.98
1.1
0.85
0.94
1.21
1.41
1.64
1.86
2.08
2.09
2.34
2.44
2.51
2.51
Tangible Book Value per Share
0.87
0.98
0.72
0.79
1.03
1.24
1.46
1.63
1.77
1.74
1.95
2.02
2.04
2.04
Basic Weighted Avg Shares
2,930
2,945
2,916
2,830
2,844
2,995
3,026
3,031
3,023
2,985
2,969
2,963
2,933
2,949
Sales/Revenue/Turnover
1,723
2,091
2,222
2,361
3,076
4,181
4,636
4,261
5,357
6,434
6,463
5,773
4,165
- -
Operating Margin (%)
27.39
29.52
24.32
27.1
27.73
26.52
27.04
17.6
18.03
22
25.19
23.28
14.02
- -
Depreciation Expense
145
193
216
247
257
283
276
317
389
371
406
456
453
- -
Net Income, GAAP
412
603
403
490
665
912
1,136
612
786
1,123
1,319
1,061
471
- -
Effective Tax Rate (%)
16.5
15.27
15.65
16.61
16.76
15.25
16.44
15.77
16.88
14.98
16.06
16.07
14.23
- -
Profit Margin (%)
23.9
28.83
18.16
20.73
21.61
21.81
24.51
14.36
14.66
17.45
20.4
18.38
11.3
- -
Working Capital
196
533
199
584
1,011
1,708
1,788
2,141
2,490
2,207
2,603
3,240
2,337
2,337
LT Debt
455
364
1,125
935
848
1,046
880
1,105
1,691
1,562
1,951
2,982
2,245
2,245
Total Equity
2,867
3,253
2,395
2,684
3,487
4,378
5,187
5,915
6,493
6,546
7,269
7,536
7,621
7,621
Return on Invested Capital (%)
10.39
12.57
10.71
12.32
14.53
16.42
17.67
8.21
8.98
12.28
13.26
10.2
4.69
- -
Return on Capital (%)
12.08
15.67
10.55
12.53
15.02
17.14
18.51
8.62
9.29
11.69
13.86
10.57
4.81
- -
Return on Common Equity (%)
15.38
19.71
14.29
19.31
21.61
23.64
24.63
11.5
13.23
18.06
20.06
15
6.48
- -

Capital Structure

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
657
721
1,769
LT Borrowings
2,981
3,297
2,244
LT Finance Leases
1
- -
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,957
2,935
2,905
Market Capitalization
10,557
8,158
8,221

Working Capital

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
5,061
5,074
4,955
Cash, Cash Equivalents & STI
1,293
1,380
1,737
Accounts Receivable, Net
2,110
2,119
1,655
Inventories
1,109
1,169
1,202
Total Current Liabilities
1,821
1,628
2,619
Payables & Accruals
- -
- -
- -
ST Debt
657
721
1,769
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.65%
5.28%
1.13%
Free Cash Flow
-89.28%
-157.66%
-706.91%
Net Income, GAAP
8.63%
2.71%
-55.65%
Sales/Revenue/Turnover
8.3%
1.55%
-27.85%
Total Cash Common Dividend
16.28%
6.76%
-20.04%

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
6,463
2024
- -
- -
5,773
2025
- -
- -
4,165

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.44
2024
- -
- -
0.36
2025
- -
- -
0.16

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.15
2024
- -
- -
0.18
2025
- -
- -
0.15

Company Description

Company Profile APIChatGPT
CEO
Ji Guang Qu
Full Time Employees
5,500
Sector
Health technology
Industry
Pharmaceuticals: major
Address
Central Plaza Hong Kong Hong Kong 200021
IPO Date
Dec 20, 2005
Website
ssygroup.com.hk
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
SSY Group Limited engages primarily in the design, manufacture, and sale of electronic products and components. Its core offerings include advanced electronic interconnect solutions, precision connectors, cable assemblies, printed circuit boards (PCBs), and related electronic manufacturing services. The company serves markets across telecommunications, consumer electronics, industrial automation, and automotive sectors. SSY Group operates and distributes its products mainly in Hong Kong, Mainland China, and other Asian markets. Founded in 2005 and headquartered in Hong Kong, SSY Group has established itself as a key supplier within the electronics manufacturing industry. In the past 1-2 years, SSY Group has made strategic moves to expand its product portfolio and strengthen market presence, including launching new high-performance connector series tailored for 5G infrastructure and automotive applications. The company has also formed strategic alliances with semiconductor and telecommunications firms to enhance supply chain integration and innovation capabilities. Additionally, SSY Group has pursued targeted acquisitions of smaller specialized component manufacturers to broaden its technological expertise and geographic reach. These initiatives support SSY Group’s strategic shift toward higher-value electronic components and integrated solutions, reinforcing its competitive position in Asia's electronics industry landscape. The company continues investing in R&D facilities and expanding manufacturing capacity to meet evolving customer demands and industry standards. SSY Group Limited operates through multiple business segments, including electronic interconnect products, electronic manufacturing services, and product design consulting. Its customer base comprises large telecommunications corporations, consumer electronics brands, automotive manufacturers, and industrial enterprises. The group's subsidiaries extend operations primarily within Greater China and select territories in Southeast Asia. It remains headquartered in Hong Kong, a strategic location that facilitates its manufacturing and global distribution network. The company emphasizes innovation, quality control, and customization as key competitive differentiators in highly technical markets. No recent name changes or reorganizations have been reported up to late 2025.